Cabergoline
NDC 0093-5420, Cabergoline, tablet, from Teva Pharmaceuticals USA, Inc..
- Product NDC
- 0093-5420
- Status
- Listed
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077750
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0093-5420 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CABERGOLINE.5 mg/1
Pharmacologic classes
Ergolines [CS]; Ergot Derivative [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0093-5420-88 | 00093542088 | 1 BOTTLE in 1 CARTON (0093-5420-88) / 8 TABLET in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/74b61e8a-7ae9-4996-85ec-df23c56de16fNADAC price for package 00093542088
GET /v1/drugs/nadac/00093542088
Use it
Look up 0093-5420 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0093-5420 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0093-5420. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.